Literature DB >> 22562809

Mitochondrial energy metabolism plays a critical role in the cardioprotection afforded by intermittent hypobaric hypoxia.

Zhi-Hua Wang1, Xiao-Long Cai, Lan Wu, Zhuo Yu, Jin-Long Liu, Zhao-Nian Zhou, Jiankang Liu, Huang-Tian Yang.   

Abstract

Intermittent hypobaric hypoxia (IHH) is an effective protective strategy against myocardial ischaemia-reperfusion (I/R) injury, but the precise mechanisms are far from clear. To understand the overall effects of IHH on the myocardial proteins during I/R, we analysed functional performance and the protein expression profile in isolated hearts from normoxic rats and from rats adapted to IHH (5000 m, 4 h day(-1), 4 weeks) following I/R injury (30 min/45 min). Intermittent hypobaric hypoxia significantly improved the postischaemic recovery of left ventricular function compared with the recovery in time-matched normoxic control hearts. Two-dimensional electrophoresis with matrix-assisted laser desorption/ionization and time-of-flight mass spectrometric analysis was then used to assess protein alterations in left ventricles from normoxic and IHH groups, with or without I/R. The expressions of 16 proteins changed by over fivefold; nine of these proteins are involved in energy metabolism. Immunoblot and real-time PCR analysis confirmed the IHH-increased expressions of the ATP synthase subunit β, mitochondrial aldehyde dehydrogenase and heat shock protein 27 in left ventricles. Furthermore, IHH significantly attenuated the reduction of myocardial ATP content, mitochondrial ATP synthase activity, membrane potential and respiratory control ratios due to I/R. In addition, inhibition of mitochondrial ATP synthase by oligomycin (1 μmol l(-1)) abolished the IHH-induced improvements in three parameters: postischaemic recovery of left ventricular function, mitochondrial membrane potential and respiratory control ratios. These results suggest that an improvement in mitochondrial energy metabolism makes an important contribution to the cardioprotection afforded by IHH against postischaemic myocardial dysfunction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22562809     DOI: 10.1113/expphysiol.2012.065102

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  10 in total

1.  Mechanistic studies on ketamine-induced mitochondrial toxicity in zebrafish embryos.

Authors:  Bonnie L Robinson; Melanie Dumas; Syed F Ali; Merle G Paule; Qiang Gu; Jyotshna Kanungo
Journal:  Neurotoxicol Teratol       Date:  2017-12-07       Impact factor: 3.763

Review 2.  Cardioprotection by intermittent hypoxia conditioning: evidence, mechanisms, and therapeutic potential.

Authors:  Robert T Mallet; Eugenia B Manukhina; Steven Shea Ruelas; James L Caffrey; H Fred Downey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-04-13       Impact factor: 4.733

3.  Dichotomous effects of chronic intermittent hypoxia on focal cerebral ischemic injury.

Authors:  Katherine A Jackman; Ping Zhou; Giuseppe Faraco; Pablo M Peixoto; Christal Coleman; Henning U Voss; Virginia Pickel; Giovanni Manfredi; Costantino Iadecola
Journal:  Stroke       Date:  2014-04-08       Impact factor: 7.914

Review 4.  Adenylate Kinase: A Ubiquitous Enzyme Correlated with Medical Conditions.

Authors:  Mihaela Ileana Ionescu
Journal:  Protein J       Date:  2019-04       Impact factor: 2.371

5.  Vascular and hepatic impact of short-term intermittent hypoxia in a mouse model of metabolic syndrome.

Authors:  Wojciech Trzepizur; Abderahim Gaceb; Claire Arnaud; Christophe Ribuot; Patrick Levy; M Carmen Martinez; Frédéric Gagnadoux; Ramaroson Andriantsitohaina
Journal:  PLoS One       Date:  2015-05-18       Impact factor: 3.240

6.  ATP synthase subunit alpha and LV mass in ischaemic human hearts.

Authors:  Esther Roselló-Lletí; Estefanía Tarazón; María G Barderas; Ana Ortega; Maria Micaela Molina-Navarro; Alba Martínez; Francisca Lago; Luis Martínez-Dolz; Jose Ramón González-Juanatey; Antonio Salvador; Manuel Portolés; Miguel Rivera
Journal:  J Cell Mol Med       Date:  2014-11-09       Impact factor: 5.310

7.  Impact of the phosphatidylinositide 3-kinase signaling pathway on the cardioprotection induced by intermittent hypoxia.

Authors:  Giuseppina Milano; Provvidenza Maria Abruzzo; Alessandra Bolotta; Marina Marini; Laura Terraneo; Barbara Ravara; Luisa Gorza; Maurizio Vitadello; Sabrina Burattini; Davide Curzi; Elisabetta Falcieri; Ludwig K von Segesser; Michele Samaja
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

8.  Molecular docking investigation of the amantadine binding to the enzymes upregulated or downregulated in Parkinson's disease.

Authors:  Mihaela Ileana Ionescu
Journal:  ADMET DMPK       Date:  2020-06-15

9.  ZFP580, a novel zinc-finger transcription factor, is involved in cardioprotection of intermittent high-altitude hypoxia against myocardial ischemia-reperfusion injury.

Authors:  Xiang-Yan Meng; Hai-Long Yu; Wen-Cheng Zhang; Tian-Hui Wang; Xia Mai; Hong-Tao Liu; Rui-Cheng Xu
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

10.  Enoyl coenzyme a hydratase domain-containing 2, a potential novel regulator of myocardial ischemia injury.

Authors:  Jianhai Du; Zhixin Li; Quan-Zhen Li; Tongju Guan; Qiuhui Yang; Hao Xu; Kirkwood A Pritchard; Amadou K S Camara; Yang Shi
Journal:  J Am Heart Assoc       Date:  2013-10-09       Impact factor: 5.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.